Half-Year Trading Update

Sales growth of more than 900%, debt-free and
significantly cashflow positive
Demand for COVID-19 test expected to continue into 2021

Paris, France and Camberley, UK – 13 July 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited trading update for the six months ended 30 June 2020.